CollPlant Biotechnologies Ltd Additional Paid in Capital, Common Stock
CollPlant Biotechnologies Ltd (CLGN) had Additional Paid in Capital, Common Stock of $126.40 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-03-26
- 2025-12-31: Additional Paid in Capital, Common Stock $126.40M.
- 2025-06-30: Additional Paid in Capital, Common Stock $126.13M.
- 2024-12-31: Additional Paid in Capital, Common Stock $122.80M.
- 2024-06-30: Additional Paid in Capital, Common Stock $121.86M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $126.40M 20-F · filed 2026-03-26 |
| 2025-06-30 | $126.13M 6-K · filed 2025-08-20 |
| 2024-12-31 | $122.80M 20-F · filed 2026-03-26 |
| 2024-06-30 | $121.86M 6-K · filed 2024-08-20 |
| 2023-12-31 | $121.07M 20-F · filed 2025-03-26 |
| 2022-12-31 | $118.10M 20-F · filed 2024-04-04 |